supply of - inj hyaluronidase 1500 iu 2 ml , eye drop polyethylene glycol 400 0 point 4 percent w slash v , eye drop atropine sulphate 1 percent w slash v bott of 3 ml , proparacaine hcl 0 point 5 percent eye drops bott of 5 ml , eye drop nepafenac 0 point 1 percent w slash v bak free rispharm , e sash d bepostatne besilate 15 mg plush potassium sorbate , e slash d sodium cromoglyicate 4 percent benzalkonium chloride solution , gel iflomax carbomer 980 plush vitamin a concentrate oil 1000 iu , e
slash d dorzolamide hydrochloride ip equivalant dorzolamide w slash v , e slash d moxifloxacin 0 point 5 percent w slash v plush loteprednol etabonate 0 point 5 percent , sulphacetamide sodium 20 percent plush chloramphenicol 0 point 5 percent , glue bibrin sealent 0 point 5 ml , new i site plus astaxanthin dha lutein resveratrol tocotrienol , moxifloxacin 0 point 5 percent eye oint 5 gm , toba f tobramycin with fluorometholone , e slash d difluprednate 0 point 05 percent sorbic acid 0 point 1 percent bott of 5 ml , promaq gummies with vitamin d3 , eye drop flurbiprofen sodium ophthalmic solution 0 point 03 percent vial of 5 ml , eye drop carboxy methyl cellulose cmc 1 percent gel , eye drop olopatadine hydrochloride 0 point 1 percent , brinzalomide benzalkonium chloride ip as preservative 0 point 01 percent , eyedrop povidone 20 mg per ml preservative free phosphate free , sterile balanced salt sol bss for opthalmic surgery , inj lignocaine hcl 2 percent without adrenaline vial of 30 ml - dglp ifa re 90 eye | quantity - 9012
Description : - inj hyaluronidase 1500 iu 2 ml , eye drop polyethylene glycol 400 0 point 4 percent w slash v , eye drop atropine sulphate 1 percent w slash v bott of 3 ml , proparacaine hcl 0 point 5 percent eye drops bott of 5 ml , eye drop nepafenac 0 point 1 percent w slash v bak free rispharm , e sash d bepostatne besilate 15 mg plush potassium sorbate , e slash d sodium cromoglyicate 4 percent benzalkonium chloride solution , gel iflomax carbomer 980 plush vitamin a concentrate oil 1000 iu , e slash d dorzolamide hydrochloride ip equivalant dorzolamide w slash v , e slash d moxifloxacin 0 point 5 percent w slash v plush loteprednol etabonate 0 point 5 percent , sulphacetamide sodium 20 percent plush chloramphenicol 0 point 5 percent , glue bibrin sealent 0 point 5 ml , new i site plus astaxanthin dha lutein resveratrol tocotrienol , moxifloxacin 0 point 5 percent eye oint 5 gm , toba f tobramycin with fluorometholone , e slash d difluprednate 0 point 05 percent sorbic acid 0 point 1 percent bott of 5 ml , promaq gummies with vitamin d3 , eye drop flurbiprofen sodium ophthalmic solution 0 point 03 percent vial of 5 ml , eye drop carboxy methyl cellulose cmc 1 percent gel , eye drop olopatadine hydrochloride 0 point 1 percent , brinzalomide benzalkonium chloride ip as preservative 0 point 01 percent , eyedrop povidone 20 mg per ml preservative free phosphate free , sterile balanced salt sol bss for opthalmic surgery , inj lignocaine hcl 2 percent without adrenaline vial of 30 ml
15
Days Left
Submission Date
03 OCT 2026
Opening Date
03 OCT 2026
Tender Estimated Cost
Refer Document
EMD
Refer Document
Apply with Surety Bond
Tender Document Fees
Refer Document
AI Bid Assistant
Prepare a complete bid response for this tender in under 30 minutes.
Tender247 tries to ensure accurate & authentic tender information at its level best however it cannot be held responsible for Omissions, Errors, etc. Users are advised to refer to Tender Document published by Procuring entity before participating / submitting bid.
LOADING...
